A proof-of-concept study will test VAS-101, a topical gel using the turmeric extract curcumin, in sickle cell disease (SCD) ...

Assessing multiple sclerosis disease activity using the MSDA blood biomarker test can help guide decisions about care, per a study.

Doctors across the United States who provide obstetrics and gynecology care have been confronted with new restrictions and ...

Unsupervised use of psilocybin has risen dramatically among youth and adults 30 and older, along with a corresponding rise in ...

According to a nurse practitioner who works in myeloma research, nurses and APPs are responsible for much of the clinical work with patients involved in trials.

Vaccinex (VCNX) will present exciting new data characterizing the unique mechanism of pepinemab to enhance immune responses to checkpoint ...

AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...

MS patients in the U.S. with Medicaid coverage have worse disease outcomes compared with those who have private insurance, a ...

Sarepta (SRPT) shared updates from its clinical programs focused on limb-girdle muscular dystrophy subtypes 2C/R5, 2D/R3, and 2E/R4. Following ...

Fintel reports that on April 14, 2025, TD Cowen downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from Buy to Hold. Analyst Price Forecast Suggests 68.84% Upside As of April 2, 2025, ...

The upcoming 15th Annual Outsourcing in Clinical Trials Europe conference will cover a wide range of topics on clinical ...

A council in South Yorkshire is funding research into the future of a local theatre following concerns about its structural viability. Rotherham Metropolitan Borough Council will spend £25,000 to ...